Trademark Search in Canada

ALLUMINOX

View On IC.GC.CA

REGISTERED

on 12 Feb 2024

Last Applicant/ Owned by

Rakuten Medical, Inc.

11080 Roselle St.San Diego CA 92121

Serial Number

2193863 filed on 6^th Apr 2022

Registration Number

TMA1221639 registered on 12^th Feb 2024

Registration expiry Date

6^th Apr 2032

Correspondent Address

DLA PIPER (CANADA) LLP

BAY ADELAIDE - WEST TOWERSUITE 5100 - 333 BAY STREETTORONTO

ONTARIO

M5H2R2

ALLUMINOX

Trademark usage description

educational services, namely, providing classes, seminars, and lectures, all in the field of treatment of cancer; education, providing training in the Read More

Classification Information

Class [041]
Educational services, namely, providing classes, seminars, and lectures, all in the field of treatment of cancer; education, providing training in the oncology field; all of the foregoing in the field of cancer and pre-cancerous prevention based on photoimmunotherapy, and cancer and pre-cancerous treatment based on photoimmunotherapy; and none of the foregoing in connection with diagnostics, genetics, and genetic sequencing.

Classification kind code

Class [042]
Scientific, biological, and medical research; advancing knowledge and developing new approaches through conducting clinical trials for others; providing prescription drug research information by means of providing links to third party websites relating to cancer drugs; providing temporary use of on-line non-downloadable software for tracking and storing personal information about the symptoms, side effects, treatment of and experience with an individual's cancer, logging daily actions and results of activity and cognitive tests, and sharing results based on such information; all of the foregoing in the field of cancer and pre-cancerous prevention based on photoimmunotherapy, and cancer and pre-cancerous treatment based on photoimmunotherapy; and none of the foregoing in connection with diagnostics, genetics, and genetic sequencing.

Classification kind code

Class [044]
Providing information in the field of health care, medical conditions, medicine and pharmaceuticals; providing medical information on pharmaceuticals and oncology platforms; providing medical and patient support information in relation to the treatment of cancer; counseling services, namely, medical counseling for patients diagnosed with cancer related to prevention and treatment; information services in the field of treating cancer; providing online information services, namely, prescription drug information; providing information in the field of medicine; providing medical information regarding medical conditions and diseases and providing information relating to the health effects of pharmaceuticals; providing an internet website featuring information and content about cancer, cancer recovery, cancer treatment, and post-cancer treatment care and survival; providing an online searchable database featuring articles and information about cancer, cancer recovery, cancer treatment, and post-cancer treatment care and survival; providing healthcare information regarding cancer drugs and cancer treatment; all of the foregoing in the field of cancer and pre-cancerous prevention based on photoimmunotherapy, and cancer and pre-cancerous treatment based on photoimmunotherapy; and none of the foregoing in connection with diagnostics, genetics, and genetic sequencing.

Classification kind code

Mark Details

Serial Number

2193863

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 27 on 27^th Oct 2023	Approval Notice Sent
Submitted for opposition 22 on 23^rd Oct 2023	Search Recorded
Submitted for opposition 256 on 24^th Apr 2023	Notification of Possible Opposition Sent
Submitted for opposition 135 on 15^th Dec 2022	Amendment to Application
Submitted for opposition 48 on 13^th Jul 2022	Agent Changed
Submitted for opposition 31 on 23^rd Jun 2022	Formalized
Submitted for opposition 257 on 23^rd Jun 2022	Designation Notification - Madrid Protocol
Submitted for opposition 1 on 23^rd Jun 2022	Created
Submitted for opposition 228 on 6^th Apr 2022	International Registration
Submitted for opposition 30 on 6^th Apr 2022	Filed